FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382196680> ?p ?o ?g. }

• W4382196680 abstract "Background Polypharmacy may affect outcomes in patients with atrial fibrillation (AF) using non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) due to interactions or reduced adherence, but comparative data are lacking. Therefore, the impact of polypharmacy on AF-related outcomes and benefit–risk profiles of NOACs in patients with polypharmacy were investigated. Methods AF patients initiating anticoagulation between 2013 and 2019 were included using Belgian nationwide data. Inverse probability of treatment weighted Cox regression was used to investigate outcomes. Results Among 254,478 AF patients, 167,847 (66.0%) used ≥5 drugs. Polypharmacy was associated with higher stroke or systemic embolism (stroke/SE) (adjusted hazard ratio [aHR]: 1.08, 95% confidence interval [CI]: 1.02–1.15), all-cause mortality (aHR: 1.45, 95% CI: 1.40–1.50), and major bleeding risks (aHR: 1.29, 95% CI: 1.23–1.35). Among patients with polypharmacy, NOACs were associated with lower stroke/SE (aHR: 0.68, 95% CI: 0.63–0.73), all-cause mortality (aHR: 0.80, 95% CI: 0.77–0.84), major bleeding (aHR: 0.92, 95% CI: 0.87–0.97), and intracranial bleeding risks (aHR: 0.77, 95% CI: 0.69–0.85), but higher gastrointestinal bleeding risks (aHR: 1.10, 95% CI: 1.01–1.19) compared to VKAs. Major bleeding risks were lower with apixaban (aHR: 0.79, 95% CI: 0.74–0.85), but nonsignificantly different with other NOACs compared to VKAs. Lower major bleeding risks were observed with dabigatran (aHR: 0.91, 95% CI: 0.85–0.97) and apixaban (aHR: 0.77, 95% CI: 0.73–0.81) compared to rivaroxaban, and with apixaban compared to dabigatran (HR: 0.83, 95% CI: 0.77–0.90) and edoxaban (HR: 0.77, 95% CI: 0.70–0.85). Conclusion Polypharmacy was associated with increased thromboembolic, bleeding, and mortality risks in AF patients. NOACs had better benefit–risk profiles than VKAs in patients with polypharmacy." @default.
• W4382196680 created "2023-06-28" @default.
• W4382196680 creator A5034910954 @default.
• W4382196680 creator A5038447227 @default.
• W4382196680 creator A5047827684 @default.
• W4382196680 creator A5062583220 @default.
• W4382196680 creator A5076311551 @default.
• W4382196680 date "2023-06-27" @default.
• W4382196680 modified "2023-10-16" @default.
• W4382196680 title "The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation" @default.
• W4382196680 cites W1871158536 @default.
• W4382196680 cites W1956185323 @default.
• W4382196680 cites W2110818436 @default.
• W4382196680 cites W2121656227 @default.
• W4382196680 cites W2159240773 @default.
• W4382196680 cites W2162499932 @default.
• W4382196680 cites W2219896033 @default.
• W4382196680 cites W2274715204 @default.
• W4382196680 cites W2275737843 @default.
• W4382196680 cites W2336267747 @default.
• W4382196680 cites W2435303807 @default.
• W4382196680 cites W2527161344 @default.
• W4382196680 cites W2763920048 @default.
• W4382196680 cites W2792857103 @default.
• W4382196680 cites W2901202385 @default.
• W4382196680 cites W2907936651 @default.
• W4382196680 cites W2912772408 @default.
• W4382196680 cites W2913889649 @default.
• W4382196680 cites W2922844093 @default.
• W4382196680 cites W2972317421 @default.
• W4382196680 cites W2998942685 @default.
• W4382196680 cites W3005123828 @default.
• W4382196680 cites W3022134567 @default.
• W4382196680 cites W3033821866 @default.
• W4382196680 cites W3082188176 @default.
• W4382196680 cites W3084099607 @default.
• W4382196680 cites W3091385685 @default.
• W4382196680 cites W3091909799 @default.
• W4382196680 cites W3137056013 @default.
• W4382196680 cites W3159673032 @default.
• W4382196680 cites W3163372954 @default.
• W4382196680 cites W3207580030 @default.
• W4382196680 cites W3214524979 @default.
• W4382196680 cites W4200153018 @default.
• W4382196680 cites W4200446523 @default.
• W4382196680 cites W4210508840 @default.
• W4382196680 cites W4210863109 @default.
• W4382196680 cites W4284886406 @default.
• W4382196680 cites W4293510396 @default.
• W4382196680 cites W4297998321 @default.
• W4382196680 cites W4307965773 @default.
• W4382196680 doi "https://doi.org/10.1055/s-0043-1769735" @default.
• W4382196680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37369234" @default.
• W4382196680 hasPublicationYear "2023" @default.
• W4382196680 type Work @default.
• W4382196680 citedByCount "1" @default.
• W4382196680 countsByYear W43821966802023 @default.
• W4382196680 crossrefType "journal-article" @default.
• W4382196680 hasAuthorship W4382196680A5034910954 @default.
• W4382196680 hasAuthorship W4382196680A5038447227 @default.
• W4382196680 hasAuthorship W4382196680A5047827684 @default.
• W4382196680 hasAuthorship W4382196680A5062583220 @default.
• W4382196680 hasAuthorship W4382196680A5076311551 @default.
• W4382196680 hasBestOaLocation W43821966801 @default.
• W4382196680 hasConcept C126322002 @default.
• W4382196680 hasConcept C127413603 @default.
• W4382196680 hasConcept C207103383 @default.
• W4382196680 hasConcept C2776301958 @default.
• W4382196680 hasConcept C2776704044 @default.
• W4382196680 hasConcept C2778810321 @default.
• W4382196680 hasConcept C2779161974 @default.
• W4382196680 hasConcept C2779668873 @default.
• W4382196680 hasConcept C2780645631 @default.
• W4382196680 hasConcept C36434225 @default.
• W4382196680 hasConcept C44249647 @default.
• W4382196680 hasConcept C50382708 @default.
• W4382196680 hasConcept C71924100 @default.
• W4382196680 hasConcept C78519656 @default.
• W4382196680 hasConceptScore W4382196680C126322002 @default.
• W4382196680 hasConceptScore W4382196680C127413603 @default.
• W4382196680 hasConceptScore W4382196680C207103383 @default.
• W4382196680 hasConceptScore W4382196680C2776301958 @default.
• W4382196680 hasConceptScore W4382196680C2776704044 @default.
• W4382196680 hasConceptScore W4382196680C2778810321 @default.
• W4382196680 hasConceptScore W4382196680C2779161974 @default.
• W4382196680 hasConceptScore W4382196680C2779668873 @default.
• W4382196680 hasConceptScore W4382196680C2780645631 @default.
• W4382196680 hasConceptScore W4382196680C36434225 @default.
• W4382196680 hasConceptScore W4382196680C44249647 @default.
• W4382196680 hasConceptScore W4382196680C50382708 @default.
• W4382196680 hasConceptScore W4382196680C71924100 @default.
• W4382196680 hasConceptScore W4382196680C78519656 @default.
• W4382196680 hasFunder F4320321730 @default.
• W4382196680 hasLocation W43821966801 @default.
• W4382196680 hasLocation W43821966802 @default.
• W4382196680 hasOpenAccess W4382196680 @default.
• W4382196680 hasPrimaryLocation W43821966801 @default.
• W4382196680 hasRelatedWork W1473422855 @default.
• W4382196680 hasRelatedWork W1997088717 @default.
• W4382196680 hasRelatedWork W2174666533 @default.

• next